InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Perros Manoussos, Chairman & CEO. Officer active across 1 companies, notably Entasis Therapeutics Holdings Inc.. Aggregated, 6 disclosures have been recorded. The latest transaction was filed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
0125,000 shares0
Common Stock
SEC:0001104659-22-005423·
0125,000 shares0
Common Stock
SEC:0001104659-22-005423:0·
€29,66511,704 shares@ €2.5346100.0% of flow
Common Stock
SEC:0001104659-21-133627·
€29,66511,704 shares@ €2.534650.0% of flow
Common Stock
SEC:0001104659-21-133627:0·
079,750 shares0
Common Stock
SEC:0001104659-21-128067·
079,750 shares0
Common Stock
SEC:0001104659-21-128067:0·
6 of 6 declarations
About Perros Manoussos
Manoussos Perros is the Chief Executive Officer of Entasis Therapeutics Holdings Inc. He leads the company's operations, focused on developing innovative treatments. His leadership is crucial to the company's mission in the pharmaceutical sector.
